StonvexLoading…
StonvexStonvexStonvexCore line items from MGX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.25M | $25.21M | $21.30M | $12.64M |
Operating Income | $-24.59M | $-96.01M | $-71.65M | $-48.81M |
Net Income | $-23.06M | $-87.87M | $-65.34M | $-19.91M |
EPS (Diluted) | $-0.61 | $-2.36 | $-1.76 | $-1.21 |
Total Assets | $196.95M | $221.10M | $247.94M | $272.28M |
Total Liabilities | $59.17M | $62.51M | $69.49M | $76.45M |
Cash & Equivalents | $25.31M | $41.72M | $32.77M | $26.85M |
Free Cash Flow OCF − CapEx | $-21.20M | $-89.47M | $-65.83M | $-44.51M |
Shares Outstanding | 37.65M | 37.62M | 37.55M | 37.53M |